Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation in vivo CRISPR gene editing ...

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Clinical laboratory professionals are transforming healthcare for expectant mothers and their babies, according to the special January issue of Clinical Chemistry published by the Association for ...

This event will highlight advances in developing and applying complex biological models, including patient-derived organoids, iPSC-based systems and CRISPR-edited constructs. Information you provide ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Focused on CRISPR-based therapies for rare diseases and oncology, this biotech just reported a notable insider sale in public ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

Plant breeders have always faced a brutal trade-off: the traits that matter most for food security, like drought tolerance or ...

In terms of liquidity and interest, the mean open interest for Regeneron Pharmaceuticals options trades today is 96.18 with a ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Cell Counting ...

Zebrafish (Danio Rerio) have emerged as a powerful bioengineering platform for next-generation drug discovery, offering an unparalleled combination of ...